Pharmaceutical News and Articles

Disparities Exist in Outpatient Referrals for Opioid Use Disorder

Black patients presenting to the emergency department for an opioid overdose are less likely to receive outpatient referrals for opioid use disorder (OUD), acco

More Florida Teens Strapping Up, Study Says

TUESDAY, July 8, 2025 More Florida teens are roaming the streets packing heat, a new study says.Handgun carrying among Florida middle and high school students i

Clash Of Drugs Impedes Lung Cancer Treatment, Lowers Survival

TUESDAY, July 7, 2025 Two drugs used in lung cancer treatment appear to be tripping over each other, reducing patients chances for a cure, a new study says.Cort

Excess Weight Increases Risk of Health Double-Whammy Among Older Women

TUESDAY, July 8, 2025 Older women carrying excess weight have a higher risk of a life-threatening double-whammy, a new study says.Women past menopause with a hi

Three-Quarters of Stomach Cancers Could Be Prevented By Targeting One Type of Bacteria

TUESDAY, July 8, 2025 Three-quarters of stomach cancer cases could be prevented if doctors eradicate infection by a common type of bacteria, a new study says.Th

Common Meds Aren't Linked To Inflammatory Bowel Disease, Study Says

TUESDAY, July 8, 2025 There s no evidence that common medications can trigger a chronic inflammatory bowel disease called microscopic colitis, a new study says.

Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics, Inc., (Nasdaq APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for differentiated efficacy

U.S. Hospitals Face Shortages in Essential Staff Due to Foreign Residency Visa Delays

a visa to enter the country. It is currently unclear precisely how many residents have been affected, but six medical residents who were interviewed by the AP s

FDA Approves Ekterly (sebetralstat) the First and Only Oral On-demand Treatment for Hereditary Angioedema (HAE)

FDA Grants Accelerated Approval to Zegfrovy (sunvozertinib) for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations